These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials. Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462 [TBL] [Abstract][Full Text] [Related]
4. Clinical impact of antibiotic resistance in respiratory tract infections. Klugman KP Int J Antimicrob Agents; 2007 Feb; 29 Suppl 1():S6-10. PubMed ID: 17307654 [TBL] [Abstract][Full Text] [Related]
5. Risk factors and clinical outcomes of penicillin resistant S. pneumoniae community-acquired pneumonia in Khon Kaen, Thailand. Reechaipichitkul W; Assawasanti K; Chaimanee P Southeast Asian J Trop Med Public Health; 2006 Mar; 37(2):320-6. PubMed ID: 17124993 [TBL] [Abstract][Full Text] [Related]
6. Doxycycline use for community-acquired pneumonia: contemporary in vitro spectrum of activity against Streptococcus pneumoniae (1999-2002). Jones RN; Sader HS; Fritsche TR Diagn Microbiol Infect Dis; 2004 Jun; 49(2):147-9. PubMed ID: 15183865 [TBL] [Abstract][Full Text] [Related]
7. Antimicrobial susceptibilities of Streptococcus pneumoniae isolated from adult patients with community-acquired pneumonia in Japan. Ishida T; Maniwa K; Kagioka H; Hirabayashi M; Onaru K; Tomioka H; Hayashi M; Tomii K; Gohma I; Ito Y; Hirai T; Ito I; Mishima M Respirology; 2008 Mar; 13(2):240-6. PubMed ID: 18339022 [TBL] [Abstract][Full Text] [Related]
8. Increase in penicillin resistance of invasive Streptococcus pneumoniae in Brazil after 1999. Brandileone MC; Casagrande ST; Guerra ML; Zanella RC; de Andrade AL; Di Fabio JL J Antimicrob Chemother; 2005 Aug; 56(2):437-9. PubMed ID: 15972313 [No Abstract] [Full Text] [Related]
9. Infection by drug-resistant Streptococcus pneumoniae is not linked to increased mortality. Yu VL; Baddour LM Clin Infect Dis; 2004 Oct; 39(7):1086-7; author reply 1087-8. PubMed ID: 15472872 [No Abstract] [Full Text] [Related]
10. What is the relevance of antimicrobial resistance on the outcome of community-acquired pneumonia caused by Streptococcus pneumoniae? (should macrolide monotherapy be used for mild pneumonia?). Low DE Infect Dis Clin North Am; 2013 Mar; 27(1):87-97. PubMed ID: 23398867 [TBL] [Abstract][Full Text] [Related]
12. [Nasopharyngeal carriage of Streptococcus pneumoniae in healthy children and multidrug resistance]. Bayer M; Aslan G; Emekdaş G; Kuyucu N; Kanik A Mikrobiyol Bul; 2008 Apr; 42(2):223-30. PubMed ID: 18697420 [TBL] [Abstract][Full Text] [Related]
13. Use of antibiotics and penicillin-resistant pneumococci: what can we learn from Iceland? Lous J Otolaryngol Head Neck Surg; 2007 Aug; 137(2):192-4. PubMed ID: 17666239 [TBL] [Abstract][Full Text] [Related]
14. Streptococcus pneumoniae of intermediate penicillin resistance causing meningitis in Auckland. Ng SO; Ellis-Pegler RB N Z Med J; 1994 Sep; 107(985):358-9. PubMed ID: 8078624 [No Abstract] [Full Text] [Related]
15. [Acute community-acquired pneumonia. A review of clinical trials]. Chidiac C Med Mal Infect; 2006; 36(11-12):650-66. PubMed ID: 16876363 [TBL] [Abstract][Full Text] [Related]